The impact of COVID-19 disease on platelets and coagulation
GD Wool, JL Miller - Pathobiology, 2021 - karger.com
Abstract Coronavirus disease 2019 (COVID-19) causes a spectrum of disease; some
patients develop a severe proinflammatory state which can be associated with a unique …
patients develop a severe proinflammatory state which can be associated with a unique …
Thrombosis in COVID‐19
Thrombotic complications are frequent in COVID‐19 and contribute significantly to mortality
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …
and morbidity. We review several mechanisms of hypercoagulability in sepsis that may be …
[HTML][HTML] Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: a different phenotype of thrombotic disease?
LF Van Dam, LJM Kroft, LI Van Der Wal… - Thrombosis research, 2020 - Elsevier
Introduction COVID-19 infections are associated with a high prevalence of venous
thromboembolism, particularly pulmonary embolism (PE). It is suggested that COVID-19 …
thromboembolism, particularly pulmonary embolism (PE). It is suggested that COVID-19 …
Venous thromboembolism in COVID-19 compared to non-COVID-19 cohorts: a systematic review with meta-analysis
Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …
Thrombo-inflammation in long COVID–the elusive key to post-infection sequelae?
Long COVID is a public health emergency affecting millions of people worldwide,
characterized by heterogenous symptoms across multiple organs systems. Here, we discuss …
characterized by heterogenous symptoms across multiple organs systems. Here, we discuss …
Management of thrombotic complications in COVID-19: an update
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …
syndrome coronavirus 2 (SARS-CoV‑2), is now a global pandemic. This virus primarily …
Vasculopathy and coagulopathy associated with SARS-CoV-2 infection
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the
causative agent of coronavirus disease 2019 (COVID-19), has resulted in> 500,000 deaths …
causative agent of coronavirus disease 2019 (COVID-19), has resulted in> 500,000 deaths …
Coronavirus disease 2019 coagulopathy: disseminated intravascular coagulation and thrombotic microangiopathy—either, neither, or both
M Levi, J Thachil - Seminars in Thrombosis and Hemostasis, 2020 - thieme-connect.com
Patients with severe coronavirus disease 2019 (COVID-19) infections manifest coagulation
abnormalities that have been associated with respiratory deterioration and death. 1, 2 In …
abnormalities that have been associated with respiratory deterioration and death. 1, 2 In …
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
The core pathology of coronavirus disease 2019 (COVID-19) is infection of airway cells by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that results in excessive …
Venous thromboembolic events in patients with COVID-19: A systematic review and meta-analysis
T Wu, Z Zuo, D Yang, X Luo, L Jiang, Z Xia… - Age and …, 2021 - academic.oup.com
Background High incidence of venous thromboembolic complications in coronavirus
disease 2019 (COVID-19) patients was noted recently. Objective This study aimed to …
disease 2019 (COVID-19) patients was noted recently. Objective This study aimed to …